Human Preadipocytes (HPAd) are derived from human adipose tissue. These fibroblast-like precursor cells are cryopreserved at the end of primary culture and can be propagated two passages prior to differentiating into Human Adipocytes (HAd). HPAd derived HAd were used to study insulin-stimulated glucose transport1,2, growth hormone enhanced lypolysis3 and obese gene expression4. HPAd can be fully differentiated into mature HAd in CAI’s Adipocyte Differentiation Medium. Significant differences in lipolysis and leptin production4 are observed in HPAd and HAd from human omental and subcutaneous adipose tissue. We provide HPAd from subcutaneous adipose tissue at various sites and adipose depot on the heart. HPAd/HAd are a useful in vitro cellular model for investigating the causes and treatment of obesity, type II diabetes and cardiovascular diseases. Recently it was discovered that human adipocytes might be a new target for the immunodeficiency virus-15.
-
Tanti, J-F. et al., Endocrinology 138(5):2005 (1997)
-
Okada, T. et al., J. Biochem Mol Biol 269(5):3568 (1994)
-
Nam, S.Y. et al., Obes Rev 1(2):73 (2000)
-
Hamilton, B.S. et al, Nature Medicine 1(9):953 (1995)
-
van Harlemen, V. et al., Diabetes 51:2029 (2002)
-
Hazan, U. et al., FASEB J. 16(10):1254 (2002)
Each lot tested negative for HIV, Hepatitis B and Hepatitis C and negative for mycoplasma, bacteria, yeast, fungi.
Products are for research use only. They are not intended for human, animal, or diagnostic applications.
|